Cargando…
Changes in interferon-γ release assay readout after COVID-19 vaccination: A prospective cohort study
OBJECTIVES: Interferon-γ release assays (IGRAs) are widely used in public health practice to diagnose latent tuberculosis. During the COVID-19 pandemic and rollout of COVID-19 vaccination, it has remained unclear whether COVID-19 vaccines interfere with IGRA readouts. METHODS: We prospectively recru...
Autores principales: | Chen, Nan-Yu, Liu, Zhuo-Hao, Kao, Shu-Wei, Lin, Huang-Shen, Lee, Ing-Kit, Zheng, Jun-Yuan, Wang, Ssu-Wei, Hsiao, Yu-Hsiang, Lin, Hui-Chin, Wu, Ting-Shu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247115/ https://www.ncbi.nlm.nih.gov/pubmed/35788418 http://dx.doi.org/10.1016/j.ijid.2022.06.044 |
Ejemplares similares
-
Risk of Tuberculosis Among Patients on Dialysis: The Predictive Value of Serial Interferon-Gamma Release Assay
por: Shu, Chin-Chung, et al.
Publicado: (2016) -
Interferon-γ release assays for tuberculous meningitis diagnosis: a meta-analysis
por: Lan, You, et al.
Publicado: (2020) -
Diagnostic Utility of Interferon-γ Release Assay in Tuberculous Lymphadenitis
por: Ye, Susu, et al.
Publicado: (2017) -
Diagnostic value of the interferon-γ release assay for tuberculosis infection in patients with Behçet’s disease
por: Wu, Xiuhua, et al.
Publicado: (2019) -
Serial testing with an interferon-γ release assay in German healthcare workers
por: Schablon, Anja, et al.
Publicado: (2010)